Anne Hermanowski‐Vosatka

Statistics

Publications

Citations

4.3K

H-Index

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rockefeller University

Brigham and Women's Hospital

United States Military Academy

Anne Hermanowski‐Vosatka is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, pharmacology, and 11 beta-hydroxysteroid dehydrogenase.

Publications per year

1988–2020

Publications

Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease.

Michael P. Lisanti, Philipp E. Scherer, Jolanta Vidugirienė et al. · The Journal of Cell Biology · 1994 · 909 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering

Carl P. Sparrow, Charlotte Burton, Melba Hernandez et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2001 · 414 citations

Medicine, Pharmacology, Pharmacotherapy +17

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng et al. · The Journal of Experimental Medicine · 2005 · 363 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14.

Samuel D. Wright, Robert Ramos, Anne Hermanowski‐Vosatka et al. · The Journal of Experimental Medicine · 1991 · 292 citations · Full text

Life Sciences, Immunology, Pathology +17

Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice

Patricia A. Detmers, Melba Hernandez, John S. Mudgett et al. · The Journal of Immunology · 2000 · 209 citations · Full text

Life Sciences, Cardiology, Inflammation +12

1–5 of 34